Synexpression group analyses identify new functions of FSTL3, a TGFβ ligand inhibitor

Biochemical and Biophysical Research Communications

Volumn 427, Issue 3, 2012, Pages 568-573

  Robertson, Rachel D ^a   Mukherjee, Abir ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Activin; Follistatin like 3 (FSTL3); Synexpression

Indexed keywords

ACTIVIN; FOLLISTATIN LIKE 3; FOLLISTATIN RELATED PROTEIN; RNA; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR SYSTEM; CELL CULTURE; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MICROARRAY; SIGNAL TRANSDUCTION; WILD TYPE;

ACTIVINS; ANIMALS; BINDING SITES; DATA MINING; GENE EXPRESSION REGULATION; LIGANDS; MICE; MICE, KNOCKOUT; ORGAN SPECIFICITY; PROMOTER REGIONS, GENETIC; PROTEINS; SMAD PROTEINS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

MUS;

EID: 84867851138     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.09.098     Document Type: Article

References (28)

1. Dohrmann C.E., Hemmati-Brivanlou A., Thomsen G.H., Fields A., Woolf T.M., Melton D.A. Expression of activin mRNA during early development in Xenopus laevis. Dev. Biol. 1993, 157:474-483.
2. Johansson B.M., Wiles M.V. Evidence for involvement of activin A and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development. Mol. Cell. Biol. 1995, 15:141-151.
3. Wiater E., Vale W. Roles of activin family in pancreatic development and homeostasis. Mol. Cell. Endocrinol. 2012, 359:23-29.
4. Bauer J., Sporn J.C., Cabral J., Gomez J., Jung B. Effects of activin and TGFβ on p21 in colon cancer. PLoS One 2012, 7:e39381.
5. Lonardo E., Hermann P.C., Mueller M.T., Huber S., Balic A., Miranda-Lorenzo I., Zagorac S., Alcala S., Rodriguez-Arabaolaza I., Ramirez J.C., Torres-Ruíz R., Garcia E., Hidalgo M., Cebrián D.A., Heuchel R., Löhr M., Berger F., Bartenstein P., Aicher A., Heeschen C. Nodal/activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. Cell Stem Cell 2011, 9:433-446.
6. Zhou S., Buckhaults P., Zawel L., Bunz F., Riggins G., Dai J.L., Kern S.E., Kinzler K.W., Vogelstein B. Targeted deletion of Smad4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells. Proc. Natl. Acad. Sci. USA 1998, 95:2412-2416.
7. Kim S.K., Hebrok M., Li E., Oh S.P., Schrewe H., Harmon E.B., Lee J.S., Melton D.A. Activin receptor patterning of foregut organogenesis. Genes Dev. 2000, 14:1866-1871.
8. Mukherjee A., Sidis Y., Mahan A., Raher M.J., Xia Y., Rosen E.D., Bloch K.D., Thomas M.K., Schneyer A.L. FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults. Proc. Natl. Acad. Sci. USA 2007, 104:1348-1353.
9. Larsson J., Goumans M.J., Sjöstrand L.J., van Rooijen M.A., Ward D., Levéen P., Xu X., ten Dijke P., Mummery C.L., Karlsson S. Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J. 2001, 20:1663-1673.
10. Ramis J.M., Collart C., Smith J.C. Xnrs and activin regulate distinct genes during Xenopus development: activin regulates cell division. PLoS One 2007, 2:e213.
11. Shi Y., Massagué J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113:685-700.
12. Kretzschmar M., Doody J., Timokhina I., Massagué J. A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras. Genes Dev. 1999, 13:804-816.
13. Hough C., Radu M., Doré J.J. Tgf-Beta induced erk phosphorylation of smad linker region regulates smad signaling. PLoS One 2012, 7:e42513.
14. Yamashita M., Fatyol K., Jin C., Wang X., Liu Z., Zhang Y.E. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Mol. Cell 2008, 31:918-924.
15. Sidis Y., Mukherjee A., Keutmann H., Delbaere A., Sadatsuki M., Schneyer A. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins. Endocrinology 2006, 147:3586-3597.
16. Stamler R., Keutmann H.T., Sidis Y., Kattamuri C., Schneyer A., Thompson T.B. The structure of FSTL3. activin A complex. Differential binding of N-terminal domains influences follistatin-type antagonist specificity. J. Biol. Chem. 2008, 283:32831-32838.
17. Bartholin L., Maguer-Satta V., Hayette S., Martel S., Gadoux M., Corbo L., Magaud J.P., Rimokh R. Transcription activation of FLRG and follistatin by activin A, through Smad proteins, participates in a negative feedback loop to modulate activin A function. Oncogene 2002, 21:2227-2235.
18. Saito S., Sidis Y., Mukherjee A., Xia Y., Schneyer A. Differential biosynthesis and intracellular transport of follistatin isoforms and follistatin-like-3. Endocrinology 2005, 146:5052-5062.
19. Tortoriello D.V., Sidis Y., Holtzman D.A., Holmes W.E., Schneyer A.L. Human follistatin-related protein: a structural homologue of follistatin with nuclear localization. Endocrinology 2001, 142:3426-3434.
20. Schneyer A., Sidis Y., Xia Y., Saito S., del Re E., Lin H.Y., Keutmann H. Differential actions of follistatin and follistatin-like 3. Mol. Cell. Endocrinol. 2004, 225:25-28.
21. Matzuk M.M., Lu N., Vogel H., Sellheyer K., Roop D.R., Bradley A. Multiple defects and perinatal death in mice deficient in follistatin. Nature 1995, 374:360-363.
22. Niehrs C., Pollet N. Synexpression groups in eukaryotes. Nature 1999, 402:483-487.
23. Matzuk M.M., Kumar T.R., Vassalli A., Bickenbach J.R., Roop D.R., Jaenisch R., Bradley A. Functional analysis of activins during mammalian development. Nature 1995, 374:354-356.
24. Topper J.N. TGF-beta in the cardiovascular system: molecular mechanisms of a context-specific growth factor. Trends Cardiovasc. Med. 2000, 10:132-137.
25. Mundel P., Heid H.W., Mundel T.M., Krüger M., Reiser J., Kriz W. Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes. J. Cell. Biol. 1997, 139:193-204.
26. Oshima Y., Ouchi N., Shimano M., Pimentel D.R., Papanicolaou K.N., Panse K.D., Tsuchida K., Lara-Pezzi E., Lee S.J., Walsh K. Activin A and follistatin-like 3 determine the susceptibility of heart to ischemic injury. Circulation 2009, 120:1606-1615.
27. Pryor-Koishi K., Nishizawa H., Kato T., Kogo H., Murakami T., Tsuchida K., Kurahashi H., Udagawa Y. Overproduction of the follistatin-related gene protein in the placenta and maternal serum of women with pre-eclampsia. BJOG 2007, 114:1128-1137.
28. Wang W., Feng L., Zhang H., Hachy S., Satohisa S., Laurent L.C., Parast M., Zheng J., Chen D.B. Preeclampsia up-regulates angiogenesis-associated microRNA (i.e., miR-17, -20a, and -20b) that target ephrin-B2 and EPHB4 in human placenta. J. Clin. Endocrinol. Metab. 2012, 97:E1051-1059.